Combination of Immunotherapy and Lung Cancer Therapies Potential Game-Changer, But Needs Further Research
August 9th 2016
Paul A. Bunn Jr, MD, discussed how combining immunotherapy with chemotherapy, molecular therapy, or anti-angiogenic therapy has shown promising results in recent randomized trials of patients with lung cancer, although the combinations have yet to demonstrate clear superiority.